Library

DMO-PHP

Extremely limited human data. All dosage and duration figures are extrapolated from user reports and close structural analogues (α-PHP, α-PVP, MDPV). Functions as a potent dopamine and norepinephrine transporter inhibitor; serotonin activity appears minimal. Acute risks include tachycardia, hypertension, vasoconstriction, hyperthermia, anxiety, paranoia, and rhabdomyolysis at high doses. Chronic use associated with insomnia, weight loss, compulsive use, psychosis, and cardiovascular strain.

Also known as: 3,4-dmohp, 3,4-dimethoxy-α-php

Classification

  • Chemical: Cathinone
  • Psychoactive: Stimulant
  • Tag: Habit-Forming
  • Tag: Pyrrolidine
  • Tag: Research-Chemical

Effects

  • Stimulation
  • Physical Euphoria
  • Bruxism
  • Vasoconstriction
  • Increased Heart Rate
  • Increased Blood Pressure
  • Cognitive Euphoria
  • Compulsive Redosing
  • Focus Enhancement
  • Motivation Enhancement
  • Increased Sociability
  • Anxiety
  • Increased Libido
  • Appetite Suppression
  • Light Sensitivity
  • Disinhibition
  • Dehydration
  • Tactile Enhancement

Routes of Administration

Oral

Dosage

  • Threshold: 5 mg
  • Light: 10 – 20 mg
  • Common: 20 – 40 mg
  • Strong: 40 – 60 mg
  • Heavy: 60 mg +

Duration

  • Onset: 0.25-0.75 h
  • Comeup: 0.5-1 h
  • Peak: 1-2.5 h
  • Offset: 1-2 h
  • After Effects: 6-24 h
  • Total Duration: 3-6 h

Insufflated

Dosage

  • Threshold: 2 mg
  • Light: 5 – 15 mg
  • Common: 15 – 30 mg
  • Strong: 30 – 50 mg
  • Heavy: 50 mg +

Duration

  • Onset: 0.08-0.17 h
  • Comeup: 0.17-0.33 h
  • Peak: 0.5-1.5 h
  • Offset: 1-2 h
  • After Effects: 6-24 h
  • Total Duration: 1.5-4 h

Smoked

Dosage

  • Threshold: 1 mg
  • Light: 3 – 10 mg
  • Common: 10 – 20 mg
  • Strong: 20 – 30 mg
  • Heavy: 30 mg +

Duration

  • Onset: 0-0.03 h
  • Comeup: 0.08-0.25 h
  • Peak: 0.25-1 h
  • Offset: 1-2 h
  • After Effects: 6-24 h
  • Total Duration: 1.5-4 h

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu

DMO-PHP - DrugsPRO vielu ceļvedis

DMO-PHP: Extremely limited human data. All dosage and duration figures are extrapolated from user reports and close structural analogues (α-PHP, α-PVP, MDPV). Functions as a potent dopamine and norepinephrine transporter inhibitor; serotonin activity appears minimal. Acute risks include tachycardia,

Related pages